A carregar...
Risk of hepatitis B reactivation during anti-TNF therapy; evaluation of patients with past hepatitis B infection
BACKGROUND/AIMS: Hepatitis B reactivation (HBVR) is an important risk of treatment with tumor necrosis factor inhibitors (anti-TNF). While antiviral prophylaxis is recommended before treatment in hepatitis B surface antigen (HBsAg) positive patients, there is no clear approach for the follow-up or p...
Na minha lista:
| Publicado no: | Turk J Gastroenterol |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Turkish Society of Gastroenterology
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7480193/ https://ncbi.nlm.nih.gov/pubmed/32897226 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5152/tjg.2020.19295 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|